title: GMP implementation in China: A double-edged sword for the pharmaceutical industry.
abstract: China's Good Manufacturing Practice (GMP) standards that mainly parallel WHO standards were made compulsory in 2004. However, GMP implementation had both positive as well as negative impacts on the pharmaceutical industry, with negatives including pharmaceutical companies suffering economic hardships, poor execution of GMP standards, and sequent health scares. This report briefly describes the problems with GMP implementation in China.
authors.affiliation: Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
authors.forename: R Y
authors.initials: RY
authors.lastname: Gai
authors.forename: X J
authors.initials: XJ
authors.lastname: Qu
authors.forename: H X
authors.initials: HX
authors.lastname: Lou
authors.forename: J X
authors.initials: JX
authors.lastname: Han
authors.forename: S X
authors.initials: SX
authors.lastname: Cui
authors.forename: M
authors.initials: M
authors.lastname: Nakata
authors.forename: N
authors.initials: N
authors.lastname: Kokudo
authors.forename: Y
authors.initials: Y
authors.lastname: Sugawara
authors.forename: C
authors.initials: C
authors.lastname: Kuroiwa
authors.forename: W
authors.initials: W
authors.lastname: Tang